St. Louis-born Galera's stock soars after release of positive study data for its experimental cancer therapy
April 30, 2021 at 11:46 AM EDT
The company, which was launched in St. Louis and still has operations here, expects to soon start dosing patients for a midstage study of the new drug candidate.
